HSP-27 has no diagnostic or prognostic significance in prostate or bladder cancers

F. Kristian Storm*, David M. Mahvi, Kennedy W. Gilchrist

*Corresponding author for this work

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Heat shock protein 27 (hsp-27) is a cytosol protein of unknown function that is concentrated in many estrogen-sensitive normal target organs and is expressed to a varying degree in many tumors, including ductal carcinoma of the breast, malignant fibrous histiocytoma (MFH) of the soft tissues, adenocarcinoma of the prostate, and transitional cell carcinoma (TCC) of the urinary bladder. Overexpression of hsp-27 has independent prognostic significance in patients with breast cancer and MFH, but its potential predictive value with prostate and bladder cancers has not been evaluated. Differential expression of hsp-27 may occur between invasive cancer and host tissue that could aid in diagnosis, and varying expression among invasive cancers may have potential prognostic significance that could influence the use of adjubant therapy. To test these hypotheses, hsp-27 expression was evaluated by immunohistochemistry in archival formalin-fixed paraffin-embedded sections of primary prostate and bladder carcinomas where the outcome of the patient was known. In 36 prostate cancer specimens from patients who had undergone radical prostatectomy (Stages T1, T2; NO; MO), no normal glandular elements or invasive cancers expressed this protein. In 24 bladder cancer specimens from patients who had undergone radical cystectomy (Stages T2, T3A, T3B, T4A; NO, N 1; MO), 12 (50%) cancers overexpressed this protein. Hsp-27 did not correlate with degree of histologic differentiation, Tstage, nodal status, local recurrence, metastases, or survival. From these observations, we conclude that hsp-27 expression has neither diagnostic nor prognostic significance and will not serve as a predictive biologic marker with these important genitourinary cancers.

Original languageEnglish (US)
Pages (from-to)379-382
Number of pages4
JournalUrology
Volume42
Issue number4
DOIs
StatePublished - Oct 1993

Fingerprint

HSP27 Heat-Shock Proteins
Urinary Bladder Neoplasms
Prostatic Neoplasms
Malignant Fibrous Histiocytoma
Neoplasms
Prostate
Urinary Bladder
Urogenital Neoplasms
Carcinoma, Ductal, Breast
Proteins
Transitional Cell Carcinoma
Cystectomy
Prostatectomy
Paraffin
Cytosol
Formaldehyde
Estrogens
Adenocarcinoma
Biomarkers
Immunohistochemistry

ASJC Scopus subject areas

  • Urology

Cite this

Storm, F. Kristian ; Mahvi, David M. ; Gilchrist, Kennedy W. / HSP-27 has no diagnostic or prognostic significance in prostate or bladder cancers. In: Urology. 1993 ; Vol. 42, No. 4. pp. 379-382.
@article{ad35237ead1b4804859b1d1a397c8c38,
title = "HSP-27 has no diagnostic or prognostic significance in prostate or bladder cancers",
abstract = "Heat shock protein 27 (hsp-27) is a cytosol protein of unknown function that is concentrated in many estrogen-sensitive normal target organs and is expressed to a varying degree in many tumors, including ductal carcinoma of the breast, malignant fibrous histiocytoma (MFH) of the soft tissues, adenocarcinoma of the prostate, and transitional cell carcinoma (TCC) of the urinary bladder. Overexpression of hsp-27 has independent prognostic significance in patients with breast cancer and MFH, but its potential predictive value with prostate and bladder cancers has not been evaluated. Differential expression of hsp-27 may occur between invasive cancer and host tissue that could aid in diagnosis, and varying expression among invasive cancers may have potential prognostic significance that could influence the use of adjubant therapy. To test these hypotheses, hsp-27 expression was evaluated by immunohistochemistry in archival formalin-fixed paraffin-embedded sections of primary prostate and bladder carcinomas where the outcome of the patient was known. In 36 prostate cancer specimens from patients who had undergone radical prostatectomy (Stages T1, T2; NO; MO), no normal glandular elements or invasive cancers expressed this protein. In 24 bladder cancer specimens from patients who had undergone radical cystectomy (Stages T2, T3A, T3B, T4A; NO, N 1; MO), 12 (50{\%}) cancers overexpressed this protein. Hsp-27 did not correlate with degree of histologic differentiation, Tstage, nodal status, local recurrence, metastases, or survival. From these observations, we conclude that hsp-27 expression has neither diagnostic nor prognostic significance and will not serve as a predictive biologic marker with these important genitourinary cancers.",
author = "Storm, {F. Kristian} and Mahvi, {David M.} and Gilchrist, {Kennedy W.}",
year = "1993",
month = "10",
doi = "10.1016/0090-4295(93)90361-D",
language = "English (US)",
volume = "42",
pages = "379--382",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "4",

}

HSP-27 has no diagnostic or prognostic significance in prostate or bladder cancers. / Storm, F. Kristian; Mahvi, David M.; Gilchrist, Kennedy W.

In: Urology, Vol. 42, No. 4, 10.1993, p. 379-382.

Research output: Contribution to journalArticle

TY - JOUR

T1 - HSP-27 has no diagnostic or prognostic significance in prostate or bladder cancers

AU - Storm, F. Kristian

AU - Mahvi, David M.

AU - Gilchrist, Kennedy W.

PY - 1993/10

Y1 - 1993/10

N2 - Heat shock protein 27 (hsp-27) is a cytosol protein of unknown function that is concentrated in many estrogen-sensitive normal target organs and is expressed to a varying degree in many tumors, including ductal carcinoma of the breast, malignant fibrous histiocytoma (MFH) of the soft tissues, adenocarcinoma of the prostate, and transitional cell carcinoma (TCC) of the urinary bladder. Overexpression of hsp-27 has independent prognostic significance in patients with breast cancer and MFH, but its potential predictive value with prostate and bladder cancers has not been evaluated. Differential expression of hsp-27 may occur between invasive cancer and host tissue that could aid in diagnosis, and varying expression among invasive cancers may have potential prognostic significance that could influence the use of adjubant therapy. To test these hypotheses, hsp-27 expression was evaluated by immunohistochemistry in archival formalin-fixed paraffin-embedded sections of primary prostate and bladder carcinomas where the outcome of the patient was known. In 36 prostate cancer specimens from patients who had undergone radical prostatectomy (Stages T1, T2; NO; MO), no normal glandular elements or invasive cancers expressed this protein. In 24 bladder cancer specimens from patients who had undergone radical cystectomy (Stages T2, T3A, T3B, T4A; NO, N 1; MO), 12 (50%) cancers overexpressed this protein. Hsp-27 did not correlate with degree of histologic differentiation, Tstage, nodal status, local recurrence, metastases, or survival. From these observations, we conclude that hsp-27 expression has neither diagnostic nor prognostic significance and will not serve as a predictive biologic marker with these important genitourinary cancers.

AB - Heat shock protein 27 (hsp-27) is a cytosol protein of unknown function that is concentrated in many estrogen-sensitive normal target organs and is expressed to a varying degree in many tumors, including ductal carcinoma of the breast, malignant fibrous histiocytoma (MFH) of the soft tissues, adenocarcinoma of the prostate, and transitional cell carcinoma (TCC) of the urinary bladder. Overexpression of hsp-27 has independent prognostic significance in patients with breast cancer and MFH, but its potential predictive value with prostate and bladder cancers has not been evaluated. Differential expression of hsp-27 may occur between invasive cancer and host tissue that could aid in diagnosis, and varying expression among invasive cancers may have potential prognostic significance that could influence the use of adjubant therapy. To test these hypotheses, hsp-27 expression was evaluated by immunohistochemistry in archival formalin-fixed paraffin-embedded sections of primary prostate and bladder carcinomas where the outcome of the patient was known. In 36 prostate cancer specimens from patients who had undergone radical prostatectomy (Stages T1, T2; NO; MO), no normal glandular elements or invasive cancers expressed this protein. In 24 bladder cancer specimens from patients who had undergone radical cystectomy (Stages T2, T3A, T3B, T4A; NO, N 1; MO), 12 (50%) cancers overexpressed this protein. Hsp-27 did not correlate with degree of histologic differentiation, Tstage, nodal status, local recurrence, metastases, or survival. From these observations, we conclude that hsp-27 expression has neither diagnostic nor prognostic significance and will not serve as a predictive biologic marker with these important genitourinary cancers.

UR - http://www.scopus.com/inward/record.url?scp=0027359372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027359372&partnerID=8YFLogxK

U2 - 10.1016/0090-4295(93)90361-D

DO - 10.1016/0090-4295(93)90361-D

M3 - Article

C2 - 8212437

AN - SCOPUS:0027359372

VL - 42

SP - 379

EP - 382

JO - Urology

JF - Urology

SN - 0090-4295

IS - 4

ER -